YongXian Li

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

First Affiliated Hospital of Guangzhou University of Chinese Medicine(Current)

Guangzhou University of Chinese Medicine

YongXian Li is an author at First Affiliated Hospital of Guangzhou University of Chinese Medicine specializing in medicine, bone resorption inhibition, and bone metabolism.

Publications per year

2019–2024

Publications

Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function

HaiShan Li, Wei Deng, Jiamin Yang et al. · Biomedicine & Pharmacotherapy · 2024 · 24 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK

HaiShan Li, Wei Deng, Qiuli Qin et al. · Biochemical Pharmacology · 2023 · 22 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity

Wei Deng, YanBo Huang, HaiShan Li et al. · Frontiers in Pharmacology · 2022 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Novel Surgical Strategy for Treating Osteoporotic Vertebral Fractures with Cord Compression

Dan‐qing Guo, Miao Yu, Shuncong Zhang et al. · Orthopaedic Surgery · 2019 · 13 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +17

Isoliensinine suppresses bone loss by targeted inhibition of RANKL-RANK binding

Wei Deng, HaiShan Li, YongXian Li et al. · Biochemical Pharmacology · 2023 · 13 citations

Medicine, Medicinal Chemistry, Pharmacology +16

1–5 of 5